Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Company news
>
2020
Company news, 2020
Endo pays $658M in a further bet on collagen-based medicines, buying out longtime biopharma partner
A little less than two years after Endo Pharmaceuticals’ deal to purchase Somerset Therapeutics fell through, the Irish drugmaker is returning to the well with a much bigger acquisition.
ChemDiv Created Unique KATO TM Platform for Development of Innovative Drugs Against Coronavirus Infection
San Diego, CA, August 12, 2020 – ChemDiv Inc.
ChemDiv, Inc. Opens the Unique Chemistry E-Commerce Store Offering the World's Largest Small Molecule Inventory at STORE.CHEMDIV.COM
STORE.
Viriom, Inc. announced the initiation of a Phase 2 clinical study to evaluate the efficacy of elsulfavirine in adults with moderate manifestations of COVID-19 (novel coronavirus).
San Diego, CA --(PR NEWSWIRE) --April 8, 2020 -- Viriom, Inc.
1
